These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17891589)

  • 1. Studies on bi-layer osmotic pump tablets of water-insoluble allopurinol with large dose: in vitro and in vivo.
    Wang X; Nie SF; Li W; Luan L; Pan W
    Drug Dev Ind Pharm; 2007 Sep; 33(9):1024-9. PubMed ID: 17891589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence of allopurinol and its metabolite oxipurinol in two tablet formulations.
    Guerra P; Frias J; Ruiz B; Soto A; Carcas A; Govantes C; Montuenga C; Fernández A
    J Clin Pharm Ther; 2001 Apr; 26(2):113-9. PubMed ID: 11350534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence of allopurinol-containing tablet preparations.
    Barthel W; Hüller G; Haustein KO
    Int J Clin Pharmacol Ther; 1999 Mar; 37(3):148-52. PubMed ID: 10190763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and comparative bioavailability of allopurinol formulations in healthy subjects.
    Helmy SA; El-Bedaiwy HM
    Clin Pharmacol Drug Dev; 2014 Sep; 3(5):353-7. PubMed ID: 27129007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monolithic osmotic tablet containing solid dispersion of 10-hydroxycamptothecin.
    Chen H; Jiang G; Ding F
    Drug Dev Ind Pharm; 2009 Feb; 35(2):131-7. PubMed ID: 19169941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals.
    Walter-Sack I; de Vries JX; Kutschker C; Ittensohn A; Voss A
    Eur J Clin Pharmacol; 1995; 49(3):215-20. PubMed ID: 8665998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and
    Li N; Fan L; Wu B; Dai G; Jiang C; Guo Y; Wang D
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1079-1088. PubMed ID: 30909753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The population pharmacokinetics of allopurinol and oxypurinol in patients with gout.
    Wright DF; Stamp LK; Merriman TR; Barclay ML; Duffull SB; Holford NH
    Eur J Clin Pharmacol; 2013 Jul; 69(7):1411-21. PubMed ID: 23475133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol.
    Wei L; Li J; Guo L; Nie S; Pan W; Sun P; Liu H
    Drug Dev Ind Pharm; 2007 Sep; 33(9):990-8. PubMed ID: 17891586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of bilayer-core osmotic pump tablets contained topiramate.
    Lin W; Li Y; Shi Q; Liao X; Zeng Y; Tian W; Xie X; Liu H
    PLoS One; 2022; 17(2):e0264457. PubMed ID: 35213658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of a push-pull osmotic pump of felodipine solubilized by mesoporous silica nanoparticles with a core-shell structure.
    Wu C; Zhao Z; Zhao Y; Hao Y; Liu Y; Liu C
    Int J Pharm; 2014 Nov; 475(1-2):298-305. PubMed ID: 25148731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on preparation and dissolution test in vitro of intragastric floating two-chamber osmotic pump tablets of total alkaloids of Coptis chinensis and Evodia rutaecarpa].
    Fang Y; Shi QW
    Zhong Yao Cai; 2011 May; 34(5):779-82. PubMed ID: 21954566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of allopurinol and oxypurinol in human plasma and urine by liquid chromatography-tandem mass spectrometry.
    Liu X; Ni XJ; Shang DW; Zhang M; Hu JQ; Qiu C; Luo FT; Wen YG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 941():10-6. PubMed ID: 24184830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release Mechanism Between Ion Osmotic Pressure and Drug Release in Ionic-Driven Osmotic Pump Tablets (I).
    Cheng L; Gao S; Ouyang D; Wang H; Wang Y; Pan W; Yang X
    AAPS PharmSciTech; 2018 Feb; 19(2):803-811. PubMed ID: 29019066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of controlled-release matrix tablets of highly water-soluble drug applying different mw polyethylene oxides (PEO) as retardants.
    Wen H; Li X; Li Y; Wang H; Wang Y; Wang T; Pan W; Yang X
    Drug Dev Ind Pharm; 2018 Apr; 44(4):544-552. PubMed ID: 29130753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and uniform evaluation of ropinirole osmotic pump tablets with REQUIP XL both in vitro and in beagle dogs.
    Li Z; Yu F; Di Z; Zhao X; Zhao S; Liu Y; Li Y; Wang Z; Gong W; Zhang H; Yang Y; Xie X; Mei X
    Drug Dev Ind Pharm; 2016 Jan; 42(1):12-18. PubMed ID: 25830369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Push-Pull Controlled Drug Release Systems: Effect of Molecular Weight of Polyethylene Oxide on Drug Release.
    Nakajima T; Takeuchi I; Ohshima H; Terada H; Makino K
    J Pharm Sci; 2018 Jul; 107(7):1896-1902. PubMed ID: 29548974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel time-controlled release system based on drug-resin complexes and elementary osmotic pump.
    Wang C; Chen F; Heng PW; Li JZ; Li X; Ye GH; Nie SF; Pan WS
    Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):457-63. PubMed ID: 18379090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release of glaucocalyxin - a self-nanoemulsifying system from osmotic pump tablets with enhanced bioavailability.
    Yanfei M; Guoguang C; Lili R; Pingkai O
    Pharm Dev Technol; 2017 Mar; 22(2):148-155. PubMed ID: 26400477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sandwiched osmotic tablet core for nifedipine controlled delivery.
    Liu L; Khang G; Rhee JM; Lee HB
    Biomed Mater Eng; 1999; 9(5-6):297-310. PubMed ID: 10822485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.